Mansor LS,Sousa FM,Yea G,et al.Inhibition of sarcolemmal FAT/CD36 by sulfo-N-succinimidyl oleate rapidly corrects metabolism and restores function in the diabetic heart following hypoxia/reoxygenation[J].Cardiovasc Res,2017,113(7):737-748.
[2]
Lopaschuk GD,Ussher JR,Folmes CD,et al.Myocardial fatty acid metabolism in health and disease[J].Physiol Rev,2010,90(1):207-258.
[3]
Kuda O,Pietka TA,Demianova Z,et al.Sulfo-N-succinimidyl oleate(SSO)inhibits fatty acid uptake and signaling for intracellular calcium via binding CD36lysine 164:SSO also inhibits oxidized low density lipoprotein uptake by macrophages[J].J Biol Chem,2013,288(22):15 547-15 555.
[4]
Danaei G,Singh GM,Paciorek CJ,et al.The global cardiovascular risk transition:associations of four metabolic risk factors with national income,urbanization,and Western diet in 1980and 2008[J].Circulation,2013,127(14):1 493-1 502,1 501e-1 502e.
[5]
Abumrad NA,El-Maghrabi MR,Amri EZ,et al.Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation.Homology with human CD36[J].J Biol Chem,1993,268(24):17 665-17 668.
[6]
Kim TT,Dyck JR.The role of CD36in the regulation of myocardial lipid metabolism[J].Biochim Biophys Acta,2016,1 861(10):1 450-1 460.
[7]
Fukushima A,Lopaschuk GD.Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes[J].Biochim Biophys Acta,2016,1 861(10):1 525-1 534.
[8]
Glatz JF,Nabben M,Heather LC,et al.Regulation of the subcellular trafficking of CD36,a major determinant of cardiac fatty acid utilization[J].Biochim Biophys Acta,2016,1 861(10):1 461-1 471.
[9]
Naville D,Duchampt A,Vigier M,et al.Link between intestinal CD36ligand binding and satiety induced by a high protein diet in mice[J].PLoS One,2012,7(1):e30686.
